News | News By Subject | News by Disease News By Date | Search News

Osteopetroses News Articles

Get Our FREE
Industry eNewsletter
Top Breaking News
Analyst: Current Crop of Biotech IPOs a Mixed Bag of Low Market Caps, Little Data     12/3/2014
Best Value In Biotech? Actavis (ACT), Says UBS     11/17/2014
Amgen (AMGN) and UCB, Inc. (UCBJF.PK) Announce Positive Phase 2 Results of AMG 785/CDP7851 in Patients With Postmenopausal Osteoporosis (PMO)     4/21/2011
US FDA Delays Approval of Amgen (AMGN) (JOBS) Osteoporosis Drug     10/20/2009
Wyeth (WYE) (JOBS) Bone Drug Reduced Fractures in Longer Study     9/15/2009
Merck & Co., Inc. (MRK) (JOBS) Loses Effort to Dismiss 24 Fosamax Cases     9/10/2009
Eli Lilly and Company (LLY) (JOBS) Halts Development of Arzoxifene for Bone Loss     8/20/2009
A Partial Approval for Amgen (AMGN)'s (JOBS) Osteoporosis Drug     8/17/2009
FDA Panel to Meet August 13 on Amgen (AMGN)'s Denosumab Drug     6/24/2009
Amgen (AMGN) Expects FDA to Set Panel Review of Bone Drug     6/10/2009
Eli Lilly and Company (LLY) Osteoporosis Drug Passes New Test     4/9/2009
Novartis Corporation (NVS) (JOBS) Bone Drug Zometa Helps Shink Breast Tumors     12/12/2008
Radius Completes Enrollment of Phase II Clinical Trial of BA058 for Osteoporosis; Milestone triggers $28.3M Second-tranche Investment     4/2/2008
Procter & Gamble (PG) Wins Patent Lawsuit for Osteoporosis Therapy Against TEVA Pharmaceuticals USA (TEVA)     2/29/2008
Amgen (AMGN) Says Denosumab vs Fosamax Trial Meets Goals     1/25/2008

News from Around the Web

Press Releases
New Analyses Of Phase 2 Study Presented At ASBMR Show Romosozumab Treatment Resulted In Continued Increases In Bone Mineral Density     9/16/2014
Unigene Laboratories, Inc. (UGNE) Doses First Patient in Phase 2 Oral PTH Study for the Treatment of Osteoporosis in Postmenopausal Women     3/15/2011
US FDA Delays Approval of Amgen (AMGN) (JOBS) Osteoporosis Drug     10/20/2009
Amgen (AMGN) Data Show Medication Adherence is an Important Factor in the Treatment of Postmenopausal Osteoporosis     9/14/2009
deCODE genetics, Inc. (DCGN) Discovers Common Genetic Variations Contributing to Low Bone Mineral Density and Risk of Osteoporosis     12/15/2008
Amgen (AMGN) Media Briefing on Current Osteoporosis Landscape     9/8/2008
Amgen (AMGN) Says Osteoporosis Drug Successful in Study     7/14/2008
Novartis Pharmaceuticals Corporation (NVS) Study Shows Once-Yearly Reclast Better than Risedronate at Increasing Bone Mass in Patients With Osteoporosis Caused by Glucocorticoids     4/11/2008
Bone Medical Ltd Positive New Data from Oral Osteoporosis Drug Trial     2/1/2008
Wyeth (WYE) Provides Update on Regulatory Review of Viviant (bazedoxifene)     12/17/2007
Nastech Pharmaceutical Company Inc. (NSTK) Announces Issuance of Patents for Parathyroid Hormone Nasal Spray for Osteoporosis and PYY Nasal Spray for Obesity     7/17/2007
Interleukin Genetics Inc. (ILGN) Completes Enrollment of Studies in Japan and China on Genetic Risk for Osteoporosis and Cardiovascular Disease     7/16/2007
NPS Pharmaceuticals, Inc. (NPSP) Announces Progression of the Calcilytics Development Program in Osteoporosis by GlaxoSmithKline (GSK)     6/5/2007
Novartis Corporation (NVS) Release: Once-yearly Reclast(R) Significantly Reduced Bone Fractures in Women with Postmenopausal Osteoporosis     5/3/2007
Osteologix Inc. Completes Enrollment in Clinical Trial of Investigational Drug for Osteoporosis     4/18/2007